ARQT
WEAKArcutis Biotherapeutics, Inc.
CIK: 0001787306
Last activity: 1 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Insider Roster (8 total, 8 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Watanabe Todd See Remarks | 0 | 3 | -$2.02M | 721,306 shares $18.39M |
| Matsuda Masaru See Remarks | 0 | 7 | -$1.15M | 114,717 shares $2.90M |
| Welgus Howard G. DIRECTOR | 0 | 3 | -$842K | 59,744 shares $1.50M |
| Burnett Patrick See Remarks | 0 | 6 | -$801K | 80,651 shares $2.08M |
| LIN SUE-JEAN DIRECTOR | 0 | 1 | -$778K | 26,735 shares $823K |
| Gilbert Halley E DIRECTOR | 0 | 1 | -$455K | 22,123 shares $609K |
| Edwards Larry Todd See Remarks | 0 | 1 | -$52K | 148,865 shares $3.80M |
| Vairavan Latha SVP Chief Financial Officer | 0 | 1 | -$34K | 63,607 shares $1.62M |
Recent Transactions
9,794 shares @ $25.81
$253K
Feb 4, 2026
19,833 shares @ $25.50
$506K
Feb 2, 2026
19,379 shares @ $25.24
$489K
Feb 2, 2026
10,000 shares @ $25.05
$250K
Feb 2, 2026
8,562 shares @ $24.97
$214K
Feb 2, 2026
7,983 shares @ $25.50
$204K
Feb 2, 2026
4,714 shares @ $25.63
$121K
Feb 2, 2026
3,675 shares @ $25.50
$94K
Feb 2, 2026
2,052 shares @ $25.50
$52K
Feb 2, 2026
1,320 shares @ $25.50
$34K
Feb 2, 2026
2,490 shares @ $28.98
$72K
Jan 5, 2026
10,000 shares @ $28.96
$290K
Jan 2, 2026
1,156 shares @ $29.39
$34K
Dec 31, 2025
541 shares @ $28.81
$16K
Dec 31, 2025
11,500 shares @ $28.94
$333K
Dec 15, 2025
10,000 shares @ $30.21
$302K
Dec 1, 2025
1,657 shares @ $30.23
$50K
Dec 1, 2025
48,945 shares @ $30.36
$1.49M
Nov 24, 2025
25,272 shares @ $30.78
$778K
Nov 24, 2025
1,055 shares @ $30.00
$32K
Nov 21, 2025
16,532 shares @ $27.55
$455K
Nov 20, 2025
1,561 shares @ $28.50
$44K
Nov 19, 2025
989 shares @ $27.95
$28K
Nov 19, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.